Prophylactic Effect of Memantine in Chronic Tension-Type Headache
NCT00315666 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2009-02-20
Summary
The purpose of this study is to test whether memantine has a prophylactic effect on chronic tension-type headaches.
Conditions
- Tension-Type Headache
Interventions
- DRUG
-
memantine
Sponsors & Collaborators
-
Danish Headache Center
lead OTHER
Principal Investigators
-
Lars Bendtsen, MD, PhD · Danish Headaches Center, Dept. of Neurology, KAS Glostrup, DK-2600 Glostrup
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2007-06-30
- Completion
- 2007-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
The Effect of Sumatriptan and Placebo on CGRP Induced Headache
NCT03542357 ·Status: COMPLETED ·Phase: NA
-
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839 ·Status: COMPLETED ·Phase: NA
-
Headache Provocation of People Who Are Unable to Have Headache
NCT04217668 ·Status: COMPLETED ·Phase: NA
-
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496 ·Status: COMPLETED
-
Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache
NCT03974360 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
NCT00806546 ·Status: COMPLETED ·Phase: PHASE3
-
Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
NCT03156920 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 ·Status: COMPLETED
-
Post-traumatic Headache Multidisciplinary Study
NCT05328635 ·Status: COMPLETED
-
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
NCT03481400 ·Status: UNKNOWN ·Phase: NA
-
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
NCT04965675 ·Status: RECRUITING ·Phase: PHASE3
-
Headache Inducing Effect of Cromakalim in Migraine Patients
NCT03228355 ·Status: COMPLETED ·Phase: NA
-
Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache
NCT05243953 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
NCT04418765 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
NCT00391755 ·Status: TERMINATED ·Phase: PHASE4
-
The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers
NCT04231617 ·Status: COMPLETED ·Phase: NA
-
Multiomics After Headache Provocation of People Who Are Unable to Have Headache
NCT04218760 ·Status: COMPLETED ·Phase: NA
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
NCT00541736 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy, Tolerability, and Safety Study of DFN-15
NCT03006276 ·Status: COMPLETED ·Phase: PHASE3
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
NCT00257985 ·Status: COMPLETED ·Phase: NA
-
Hypersensitivity to PACAP-38 in Post-Traumatic Headache
NCT05378061 ·Status: UNKNOWN ·Phase: NA
-
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
NCT03308968 ·Status: COMPLETED ·Phase: PHASE3
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
NCT03238781 ·Status: COMPLETED ·Phase: PHASE2